Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Interim Condensed Consolidated Statements of Comprehensive Loss (Unaudited)

v3.19.2
Interim Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Profit or loss [abstract]    
Revenues $ 688 $ 902
Research and development expenses (3,960) (2,638)
General and administrative expenses (1,333) (1,819)
Operating loss (4,605) (3,555)
Finance expenses (324) (346)
Finance income 36 936
Total financial income (expense), net (288) 590
Net loss $ (4,893) $ (2,965)
Net loss per share attributable to equity holders of the Company:    
Basic and diluted net loss per share $ (0.08) $ (0.08)